Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction

Europace

Volumn 2, Issue 3, 2000, Pages 207-215

  Kulakowski, P ^a   Karczmarewicz, S ^a   Karpinski G ^a   Soszynska M ^a   Ceremuzynski L ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

Author keywords

Intravenous amiodarone; Intraventricular conduction; Refractoriness

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CONDUCTION;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HEART CONDUCTION SYSTEM; HUMANS; INJECTIONS, INTRAVENOUS; MALE; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TACHYCARDIA, VENTRICULAR;

EID: 0034231325     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2000.0099     Document Type: Article

References (16)

1. Kowey PR, Levine JH, Herre JM. Randomised, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 92:1995;3255-3263.
2. Scheinman MM, Levine JH, Cannom DS. Dose-ranging study of intravenous amiodarone in patients with lifethreatening ventricular tachyarrhythmias. Circulation. 92:1995;3264-3272.
3. Levine JH, Massumi A, Scheinman M. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol. 27:1996;67-75.
4. Gomes JAC, Kanf PS, Hariman RJ, El-Sherif N, Lyons J. Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. Am Heart J. 107:1984;214-221.
5. Singh BN, Nademanee K, Kannan R, Ikeda N. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. PACE. 7:1984;109-124.
6. Morady F, DiCarlo LA, Krol RB, Baerman JM, Buitleir de M. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. J Am Coll Cardiol. 7:1986;148.
7. Kulakowski P, Bashir Y, Heald S. Effects of procainamide on the signal-averaged electrocardiogram in relation to the results of programmed ventricular stimulation in patients with sustained monomorphic ventricular tachycardia. J Am Coll Cardiol. 21:1993;1428-1439.
8. Borbola J, Denes P. Oral amiodarone loading therapy. 1. The effect on signal-averaged electrocardiographic recordings and on the QTc in patients with ventricular tachyarrhythmias. Am Heart J. 115:1988;1202-1208.
9. Du X-J, Murray DE, Dart AM. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation. 91:1995;462-470.
10. Kojima S, Wu ST, Wikman-Coffelt J, Parmley WW. Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts. J Pharm Exp Ther. 275:1995;254-262.
11. Mayuga RD, Singer DH. Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies. Cardiovasc Res. 26:1992;571-579.
12. Gough WB, Zeiler RH, Barecca P. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol. 4:1982;375-380.
13. Gallik DM, Meissner MD, Communale M, Singer I, Hanin L. Favorable hemodynamic effects of Amio-AqueousR, a new formulation of intravenous amiodarone (Abstr). Circulation. 96:1997;1-383.
14. Hohnloser SH, Meinertz T, Demmbacher T,. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone. Results of a prospective placebo-controlled study. Am Heart J. 121:1991; 89-95.
15. Kowey PR, Marinchak RA, Rials SJ, Filart RA. Intravenous amiodarone. J Am Coll Cardiol. 29:1997;1190-1198.
16. Venkatesh N, Somani P, Bersohn M. Electropharmacology of amiodarone: absence of relationship to serum, myocardial, and cardiac sarcolemmal membrane drug concentrations. Am Heart J. 112:1986;916-922.